Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 03763A207 since 12/18/2024, newest first.
| Filer | % of Class | Filed |
|---|---|---|
| Vanguard Portfolio Management LLC 13G | 5.3% |
7/31/2026
Event 6/30/2026
|
| Vanguard Group Inc 13G/A Amendment 5 | 0% |
3/26/2026
Event 3/13/2026
|
| Vanguard Group Inc 13G/A Amendment 4 | 8.5% |
1/30/2026
Event 12/31/2025
|
| Vanguard Group Inc 13G/A Amendment 3 | 9.7% |
7/29/2025
Event 6/30/2025
|
| BlackRock, Inc. 13G/A Amendment 6 | 12.4% |
4/17/2025
Event 3/31/2025
|
| ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSIONAL MEDICAL Corp 13D/A Amendment 9 | 11.0% |
2/18/2025
Event 2/15/2025
|
| BlackRock, Inc. 13G | 11.4% |
2/5/2025
Event 12/31/2024
|
| ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSIONAL MEDICAL Corp 13D/A Amendment 8 | 12.2% |
1/22/2025
Event 1/17/2025
|
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 12 | 478 k | $11.4 M |
| 2026 Q2 | 219 | 34.5 M | $1.54 B |
| 2026 Q1 | 179 | 29.9 M | $733 M |
| 2025 Q4 | 182 | 29.1 M | $724 M |
| 2025 Q3 | 196 | 26.8 M | $761 M |
| 2025 Q2 | 169 | 26.1 M | $649 M |
| 2025 Q1 | 175 | 26.2 M | $813 M |
| 2024 Q4 | 185 | 26.1 M | $822 M |
| 2024 Q3 | 198 | 25.4 M | $1.47 B |
| 2024 Q2 | 182 | 23.5 M | $951 M |
| 2024 Q1 | 170 | 23.6 M | $989 M |
| 2023 Q4 | 152 | 22.8 M | $873 M |
| 2023 Q3 | 139 | 21.5 M | $664 M |
| 2023 Q2 | 135 | 20.8 M | $656 M |
| 2023 Q1 | 138 | 20.0 M | $731 M |
| 2022 Q4 | 139 | 21.2 M | $629 M |
| 2022 Q3 | 166 | 19.9 M | $775 M |
| 2022 Q2 | 143 | 18.0 M | $719 M |
| 2022 Q1 | 152 | 17.7 M | $1.12 B |
| 2021 Q4 | 165 | 17.2 M | $1.26 B |
| 2021 Q3 | 148 | 16.7 M | $1.52 B |
| 2021 Q2 | 107 | 10.3 M | $644 M |
| 2021 Q1 | 78 | 6.36 M | $172 M |
| 2020 Q4 | 65 | 5.30 M | $96.8 M |
| 2020 Q3 | 65 | 5.06 M | $90.7 M |
| 2020 Q2 | 52 | 4.20 M | $69.2 M |
| 2020 Q1 | 53 | 3.51 M | $45.4 M |
| 2019 Q4 | 56 | 3.84 M | $70.7 M |
| 2019 Q3 | 47 | 5.57 M | $98.1 M |
| 2019 Q2 | 37 | 2.85 M | $47.6 M |
| 2019 Q1 | 40 | 2.40 M | $44.0 M |
| 2018 Q4 | 42 | 2.59 M | $51.4 M |
| 2018 Q3 | 41 | 2.40 M | $52.9 M |
| 2018 Q2 | 34 | 2.65 M | $68.6 M |
| 2018 Q1 | 13 | 542 k | $8.64 M |
| 2017 Q4 | 6 | 50.4 k | $1.21 M |